Subclinical AF: Apixaban reduces Stroke risk, albeit at a higher bleeding risk, ATRESiA trial dr. Abhimanyu Uppal15 Nov 2023 4:30 PM ISTSubclinical atrial fibrillation (AF), characterized by brief episodes identified through a device capable of continuous, long-term arrhythmia...
Edoxaban emerges as effective anticoagulant option in children with cardiac disease, JACC study. dr. Abhimanyu Uppal15 Dec 2022 9:45 AM ISTStandard of care (SOC) anticoagulation for thromboembolism (TE) prevention in children with cardiac disease includes low molecular weight heparins or...
Apixaban better than rivaroxaban for AF patients with valvular heart disease: study dr. Abhimanyu Uppal28 Oct 2022 12:15 PM ISTAlthough apixaban and rivaroxaban are commonly used in patients with atrial fibrillation (AF) and valvular heart disease (VHD), there is limited...
Rivaroxaban alone better than combination therapy for stable CAD patients with AF, JAMA study. dr. Abhimanyu Uppal3 July 2022 8:00 PM ISTAppropriate regimens of antithrombotic therapy for patients with atrial fibrillation (AF) and coronary artery disease (CAD) have not yet been...
Recent NOAC use does not increase ICH risk in stroke patients undergoing thrombolysis: JAMA study dr. Abhimanyu Uppal7 March 2022 10:00 AM ISTContrary to the guidelines that recommend against use of intravenous alteplase in patients with acute ischemic stroke who are taking non–vitamin K...
NOACs associated with lower risk for diabetic complications and mortality compared with warfarin Hina Zahid15 Feb 2022 9:00 AM ISTA retrospective cohort study of patients with atrial fibrillation and diabetes found that the use of non–vitamin K antagonist oral anticoagulants...
Study cautions against use of oral anticoagulants in admitted COVID patients, ACC 2021 dr. Abhimanyu Uppal19 May 2021 9:00 AM ISTEvidence over last one and half year has suggested that COVID-19 is characterized by a prothrombotic state, with perhaps a much higher thrombotic risk...
The unknown risk of dementia with DOACs, a BMJ report Dr. Shivi Kataria12 March 2021 10:45 AM ISTIn what may be cited as the first-ever reported neurocongnitive side-effects of newer anticoagulants rivaroxaban and apixaban (belonging to the class...
2020 in a nutshell: The hottest developments in field of cardiology this year. Section 2. Atrial fibrillation dr. Abhimanyu Uppal25 Dec 2020 8:45 AM ISTExciting researches continue to swirl around the niche of atrial fibrillation and its management. The year 2020 marked the advent of cryoablation as a...
